Denmark-based Lundbeck has received marketing authorisation from Japan’s Ministry of Health, Labour and Welfare fo...
India-based Gujarat Themis Biosyn Limited (GTBL) has announced the completion of the acquisition of 100% equity sharehol...
Eisai Co. and Biogen Inc. have announced that LEQEMBI® Pen, the subcutaneous (SC) formulation of the anti-amyloid be...
Japan-based Shimadzu Corporation has merged its UK group company, Shimadzu Research Laboratory (Europe) into Kratos Anal...
Viome Life Sciences, Inc., the US precision health company known for its diagnostic testing and personalised nutrition r...
Nipro Corporation, a global healthcare and medical technology company, has announced the establishment of its Asia Pacif...
Teijin Limited, Teijin Regenet Co., Ltd., and Shinshu University Hospital have entered into a joint research agreement r...
Japan-based Hodogaya Chemical has established a subsidiary to promote the nucleic acid therapeutics CDMO business. In it...
Japan-based Shionogi has received marketing authorisation from the Therapeutic Goods Administration (TGA) in Australia f...
Japan-based Ono Pharmaceutical has entered into a drug discovery partnership agreement with US-based Aitia, Inc. Under t...
South Korea-based Samsung Bioepis has announced the marketing approval of Ustekinumab BS Intravenous Infusion 130mg...
Australian cellular health company Longevity Life Sciences has entered into a multi-year strategic partnership with Mits...
Japan-based PENTAX Medical, a HOYA Group company, has announced the expansion of its partnership with MAGENTIQ EYE, exte...
Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from The University of Tokyo, through...
Drug delivery technologies have become increasingly important as pharmaceutical developers work with complex molecules, ...
SkyDrive Inc., a leading Japanese developer, manufacturer, and seller of compact eVTOL (electric vertical takeoff and la...
Novotech, a leading global biotech CRO and full-service clinical research organisation, has strengthened its established...
US-based Pillar Biosciences, Inc., LC-SCRUM-Asia and LSI Medience Corporation have announced a collaboration to support ...
Japan-based Chugai Pharmaceutical has signed an exclusive license agreement with British pharma firm GlaxoSmithKline (GS...
LEO Pharma, a global leader in medical dermatology delivering innovative solutions for skin disease, has entered into an...
Adneuris Therapeutics, a wholly owned subsidiary of Tris Pharma advancing a new kind of pain medicine, has entered ...
German technology consulting and IT services company adesso SE and Japan-based Hitachi Digital Services have announ...
Japan-based Chugai Pharmaceutical and the University of California, San Francisco (UCSF) have entere...
Counterfeit and unauthorised healthcare products remain a persistent risk across Asia, particularly where fragmented dis...
Fujifilm Corporation and Taiho Pharmaceutical have entered into a strategic partnership agreement for the development of...
